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Abstract
We are a group of researchers and academics with decades of experience in
the protection and promotion of public health. We are writing to raise our
concerns about how conflicts of interest are reported in public health nutrition
research. We highlight examples of why it is important to accurately declare
such conflicts, as well as providing examples of situations in which conflicts of
interest have been inadequately reported. We call on researchers, and others,
to be transparent about conflicts of interest in research. Journal editors in
particular have an important responsibility in fully understanding how conflicts
of interest can impact on research findings. They need to agree and adopt clear
guidelines on conflicts of interest and ensure that authors abide by these to
facilitate trust in the scientific process and the credibility of published articles.
Keywords
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Interactions between commercial food and drink companies1 
and professionals and bodies responsible for improving public 
health and health promotion have generated concerns for 
decades1–3. These interactions are often hailed as unique oppor-
tunities to make a difference to the public’s health that would 
otherwise not be possible without industry involvement3. In late 
2018, a series of events attracted considerable media attention in 
the United Kingdom and beyond. In September, Public Health 
England announced their partnership with the alcohol indus-
try-funded body DrinkAware on a campaign called ‘Drink Free 
Days’, which has the stated aim of helping people cut down on 
the amount of alcohol they are regularly drinking. This part-
nership was met with much criticism – with Public Health 
England’s alcohol adviser, Sir Ian Gilmore, resigning from this 
role because of concerns that such interactions with alcohol indus-
try actors and related industry-funded organisations come at the 
expense of public health4. Then, in late November, Diabetes UK 
announced that it had joined forces with sugar-sweetened bever-
age manufacturer Britvic in a three-year partnership. Again, this 
interaction was met with much public criticism, which Diabetes 
UK has rejected5. On a more positive note, in October 2018 the 
Dieticians Association of Australia terminated partnerships with 
food manufacturers and industry associations following long- 
standing criticism and internal member advocacy6.
Such interactions with industry are also common among 
individual researchers. In a recent article published in the British 
Medical Journal, van Tulleken reported that cow’s milk allergy 
may be acting as a Trojan horse for the €44bn global breastmilk 
substitute industry to forge relationships with healthcare profes-
sionals in the UK and around the world7. He further highlighted 
that many of those involved in producing milk allergy guidelines 
declared interests with breastmilk substitute manufacturers either 
at the time of writing or subsequently. A series of recent studies 
have highlighted links between nutrition researchers and Coca 
Cola8,9, contributing to a narrative that pushes policy towards 
measures to increase exercise by children, which is of course 
a good thing, while deflecting attention from the role of sugar- 
sweetened beverages in obesity and poor nutrition. Such interac-
tions between public health, paediatric and nutrition experts and 
commercial food and drink companies can undermine trust in 
researchers and their scientific integrity10,11.
Concerns about interactions between researchers and commer-
cial food and drink companies are well-founded as corporate 
interests typically prioritise investing in research that supports 
their policy and legal positions, and this can divert research 
attention away from questions that are more pressing for public 
health12,13. Such interactions are also more likely to lead to find-
ings that confirm the benefits or lack of harm of the sponsor’s 
products14, even when independently sponsored research comes 
to differing conclusions. As early as 1965 the US sugar industry 
began funding research to downplay the role of sugar as a 
dietary risk factor for coronary heart disease, shifting the 
focus towards cholesterol and fat instead, with decades-long 
implications for nutrition guidance and policy15. A Cochrane 
review concluded that industry sponsored studies more often 
report findings in a direction that favours the sponsor16. Similarly, 
in a systematic review of the effects of soft drink consumption 
on nutrition and health, the authors found that studies funded by 
the food industry reported significantly smaller effects than did 
non–industry-funded studies17. Such industry-funded research 
generates doubt among scientists, policy-makers and the pub-
lic by generating conflicting or confusing results18. In the light of 
these and other revelations, members of the public are increas-
ingly sceptical about research that is supported by commercial 
funding19, as are members of the research community20.
An important element of maintaining public trust in the scien-
tific process and the credibility of published articles is whether 
conflicts of interest are transparently disclosed during the plan-
ning, implementation, writing, peer review, editing, and publica-
tion of scientific work. Determining what constitutes a conflict of 
interest can be difficult for researchers and editors as there is 
limited guidance available. However, when researchers receive 
funding from a commercial company to undertake research related 
to their products, brand or area of interest, a conflict of interest 
exists21. Although this seems obvious, a number of corporations 
have supported positions that seek to dismiss concerns about such 
conflicts by arguing that everyone has some interest, for exam-
ple, in progressing their scientific reputation to attract further 
funding, so commercial sponsorship should not raise particular 
concerns22.
Procedures for the reporting of conflicts of interest are covered 
within the International Committee of Medical Journal Editors 
(ICJME) guidelines. Where authors do not conform to ICJME 
guidelines, journal editors must take responsibility for encour-
aging full disclosure. A common sentiment within the research 
community is that transparency is the key to appropriately 
managing and avoiding conflicts of interest; that is, as long as 
the authors are fully transparent, then readers can make up their 
own minds about conflicts of interest. However, this sentiment 
fails to acknowledge the limited understanding both academic 
and clinical researchers have on this issue23,24. Of particular 
concern is the limited awareness of how research funding and 
unconscious bias work together. This relationship can result in 
researchers being influenced by funding even when they think 
they are being unbiased25. Further limitations of disclosure are 
apparent from research showing that it may give licence to 
researchers to exaggerate their findings, while reviewers often fail 
to take adequate account of its significance26.
Recently in a scientific article published ahead of print in Annals 
of Nutrition and Metabolism, the authors of the article stated that 
they had “no conflicts of interest or financial ties to disclose” 
despite declaring that the writing of the article was supported 
by Nestlé Nutrition Institute27. This Institute has clear links with 
Nestlé28, the world’s biggest breast-milk substitute and comple-
mentary baby food manufacturer29, and therefore it has a clear 
financial interest in the study30. We wrote a Letter to the Editor 
of the journal to raise our concerns about how conflicts of 
1Those involved in the primary production, manufacturing, wholesaling, retail-
ing of fresh, packaged, or hot or cold ready-to-eat foods and/or drinks, as well 
as third parties working for such companies, including trade associations and 
research bodies.
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interest were reported therein. The Editor declined to accept our 
letter for publication asserting that the authors had disclosed 
their funding source and that readers could apply their own 
interpretation. The Editor further stated that the Editorial Board 
would critically review and question conflict of interest (COI) 
statements where questions may arise, but added that COI 
declaration remains the responsibility of the authors (personal 
communications). While COI is the responsibility of the authors 
to declare, it is the responsibility of the journal to have robust 
policies and to clearly explain them in a way that leaves no room 
for ambiguity.
The practice of declaring no conflicts of interest while also 
reporting financial support from vested interests is not uncom-
mon in early life nutrition research. This occurs despite the World 
Health Organisation highlighting the need to avoid conflicts of 
interest in all areas relating to infant and young child feeding in 
at least eight World Health Assembly resolutions. In a paper 
outlining the recommendations of an International Expert 
Group around follow-up formula for infants, several authors 
reported financial ties with breast-milk substitute companies 
yet declared that “none of the authors reports a conflict of 
interest”31. Shortcomings in editorial policies toward con-
flicts of interest (financial and nonfinancial) of editors and other 
staff involved in manuscript decisions have previously been 
highlighted32. Indeed, the ICJME guidelines that that all those 
involved in the peer-review and publication process, including 
authors, peer reviewers, editors, and editorial board members 
of journals, must consider their conflicts of interest and disclose 
all relationships that could be viewed as conflicts of interest.
Researchers and journals have important responsibilities regard-
ing conflicts of interest33. It is time to for researchers, journals, 
funders and others involved in the research process, to engage 
more critically with the challenges of conflicts of interest in 
research. This requires clear understanding of what is, and is 
not, a conflict of interest, how to identify them, the impacts of 
conflicts of interest on scientific integrity, how to prevent 
them, and greater transparency in the reporting of conflicts of 
interest in research, something that is often lacking34. Journal 
editors in particular have an important responsibility in fully 
understanding how conflicts of interest can impact on research 
findings and the credibility of published articles for journals and 
authors.
Clear guidelines on managing interactions with commercial 
food and drink companies, including avoidance of damaging 
conflicts of interest, are urgently needed. Journals will need to 
play an important role in implementing such guidance. To aid 
in this process, a project funded by the UK’s Medical Research 
Council has reviewed evidence and built international consen-
sus on the principles that underpin governance of interactions 
between researchers and commercial food and drink compa-
nies. Guidance for researchers, journals and funders will be 
published in 201935. It will enable researchers to identify and 
assess conflicts of interest at different stages of the research 
process and suggests governance strategies to manage these.
Journals – as well as research institutions, professional bodies 
and funders – should use this forthcoming guidance to formulate 
or update their own conflict of interest policies and ensure that 
authors, peer reviewers, editors, and editorial board members 
abide by these to promote trust in the scientific process and the 
credibility of published articles.
Disclaimer
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Publication in HRB Open Research does not imply endorsement 
by the Health Research Board of Ireland.
Data availability
No data is associated with this article.
Grant information
MH is a PhD Scholar funded by the Health Research Board under 
SPHeRE/2013/1. The Health Research Board had no role in 
study design, data collection and analysis, decision to publish, or 
preparation of the manuscript.
KC is funded by a grant from the Australian Government’s 
Medical Research Future Fund.
MM received a grant number 2017/24744-0, from the São Paulo 
Research Foundation (FAPESP), Brazil. The authors are solely 
responsible for the opinions, hypotheses and conclusions or 
recommendations expressed in this publication, and they do not 
necessarily reflect FAPESP’s vision.
MW holds grants from the UK Medical Research Coun-
cil to develop guidance on managing interactions between 
researchers and commercial food and drink compa-
nies; and with the UK National Institute of Health 
Research (NIHR) to evaluate the UK’s Soft Drinks Industry 
Levy. MW is also funded as Director of NIHR’s Public Health 
Research Programme.  
The funders had no role in study design, data collection and 
analysis, decision to publish, or preparation of the manuscript.
References
1. Durand MA, Petticrew M, Goulding L, et al.: An evaluation of the Public Health 
Responsibility Deal: Informants’ experiences and views of the development, 
implementation and achievements of a pledge-based, public-private partnership 
to improve population health in England. Health Policy. 2015; 119(11): 1506–14.  
PubMed Abstract | Publisher Full Text 
2. Galea G, McKee M: Public-private partnerships with large corporations: 
setting the ground rules for better health. Health Policy. 2014; 115(2–3): 138–40. 
PubMed Abstract | Publisher Full Text 
3. Nestle M: Food company sponsorship of nutrition research and professional 
activities: a conflict of interest? Public Health Nutr. 2001; 4(5): 1015–22.  
PubMed Abstract | Publisher Full Text 
4. Petticrew M, McKee M, Marteau TM: Partnerships with the alcohol industry at 
Page 4 of 5
HRB Open Research 2019, 2:1 Last updated: 31 JAN 2019
the expense of public health. Lancet. 2018; 392(10152): 992–993.  
PubMed Abstract | Publisher Full Text 
5. Woodfield J: Diabetes UK defends sponsorship deal with Britvic. London: 
Diabetes UK. 2018; [cited 2018 December 17]. 
Reference Source
6. Dieticians Association of Australia: Public announcements: Conclusion of DAA’s 
Corporate Partnerships Program. Sydney: Dieticians Association of Australia. 
2018; [cited 2018 December 17].   
Reference Source
7. van Tulleken C: Overdiagnosis and industry influence: how cow’s milk protein 
allergy is extending the reach of infant formula manufacturers. BMJ. 2018; 363: 
k5056.  
PubMed Abstract | Publisher Full Text 
8. Stuckler D, Ruskin G, McKee M: Complexity and conflicts of interest statements: 
a case-study of emails exchanged between Coca-Cola and the principal 
investigators of the International Study of Childhood Obesity, Lifestyle and the 
Environment (ISCOLE). J Public Health Policy. 2018; 39(1): 49–56.  
PubMed Abstract | Publisher Full Text 
9. Barlow P, Serôdio P, Ruskin G, et al.: Science organisations and Coca-Cola’s 
‘war’ with the public health community: insights from an internal industry 
document. J Epidemiol Community Health. 2018; 72(9): 761–3.  
PubMed Abstract | Publisher Full Text | Free Full Text 
10. Kraak V, Swinburn B, Lawrence M, et al.: The accountability of public-private 
partnerships with food, beverage and quick-serve restaurant companies to 
address global hunger and the double burden of malnutrition. In: Coitinho 
Delmuè D, Mahy L, Ionata S editors. SCN News: Nutrition and Business: How to 
engage? Rome: United Nations System Standing Committee on Nutrition; 2011;  
39: 11–24.  
Reference Source
11. Gavin B: A qualitative study of UNSCN Steering Committee and Working Group 
facilitators views on engagement with the private industry. In: Coitinho Delmuè 
D, Mahy L, Ionata S, editors. SCN News: Nutrition and Business: How to engage? 
Rome: United Nations System Standing Committee on Nutrition; 2011; 39:  
66–72.
12. Fabbri A, Lai A, Grundy Q, et al.: The Influence of Industry Sponsorship on the 
Research Agenda: A Scoping Review. Am J Public Health. 2018; 108(11): 
e9–e16.  
PubMed Abstract | Publisher Full Text | Free Full Text 
13. Fabbri A, Chartres N, Scrinis G, et al.: Study sponsorship and the nutrition 
research agenda: analysis of randomized controlled trials included in 
systematic reviews of nutrition interventions to address obesity. Public Health 
Nutr. 2017; 20(7): 1306–13.  
PubMed Abstract | Publisher Full Text 
14. Nestle M: Food Industry Funding of Nutrition Research: The Relevance of 
History for Current Debates. JAMA Intern Med. 2016; 176(11): 1685–6.  
PubMed Abstract | Publisher Full Text 
15. Kearns CE, Schmidt LA, Glantz SA: Sugar Industry and Coronary Heart Disease 
Research: A Historical Analysis of Internal Industry Documents. JAMA Intern 
Med. 2016; 176(11): 1680–5.  
PubMed Abstract | Publisher Full Text | Free Full Text 
16. Lundh A, Lexchin J, Mintzes B, et al.: Industry sponsorship and research 
outcome. Cochrane Database Syst Rev. 2017; 2: MR000033.  
PubMed Abstract | Publisher Full Text 
17. Vartanian LR, Schwartz MB, Brownell KD: Effects of soft drink consumption 
on nutrition and health: a systematic review and meta-analysis. Am J Public 
Health. 2007; 97(4): 667–75.  
PubMed Abstract | Publisher Full Text | Free Full Text 
18. Diethelm PA, Rielle JC, McKee M: The whole truth and nothing but the truth? 
The research that Philip Morris did not want you to see. Lancet. 2005; 
366(9479): 86–92.  
PubMed Abstract | Publisher Full Text 
19. Besley JC, McCright AM, Zahry NR, et al.: Perceived conflict of interest in health 
science partnerships. PLoS One. 2017; 12(4): e0175643.  
PubMed Abstract | Publisher Full Text | Free Full Text 
20. McCambridge J, Mialon M: Alcohol industry involvement in science: A 
systematic review of the perspectives of the alcohol research community. 
Drug Alcohol Rev. 2018; 37(5): 565–79.  
PubMed Abstract | Publisher Full Text | Free Full Text 
21. Lo B, Field MJ, editors. Institute of Medicine (US) Committee: Conflict of Interest 
in Medical Research, Education, and Practice. Washington (DC): National 
Academies Press (US); 2009.  
PubMed Abstract | Publisher Full Text 
22. McCambridge J, Daube M, McKee M: Brussels Declaration: a vehicle for the 
advancement of tobacco and alcohol industry interests at the science/policy 
interface? Tob Control. 2019; 28(1): 7–12.  
PubMed Abstract | Publisher Full Text 
23. Bero LA: Accepting commercial sponsorship. Disclosure helps--but is not a 
panacea. BMJ. 1999; 319(7211): 653–4.  
PubMed Abstract | Publisher Full Text | Free Full Text 
24. Goldberg DS: The shadows of sunlight: Why disclosure should not be a priority 
in addressing conflicts of interest. Public Health Ethics. 2018.  
Publisher Full Text 
25. Capps B: Can a good tree bring forth evil fruit? The funding of medical 
research by industry. Br Med Bull. 2016; 118(1): 5–15.  
PubMed Abstract | Publisher Full Text | Free Full Text 
26. Cain D, Loewenstein G, Moore D: The dirt on coming clean: Perverse effects of 
disclosing conflicts of interest. J Legal Stud. 2005; 34(1): 1–25.  
Publisher Full Text 
27. Laving AR, Hussain SR, Atieno DO: Overnutrition: Does Complementary 
Feeding Play a Role? Ann Nutr Metab. 2018; 73 Suppl 1: 15–8.  
PubMed Abstract | Publisher Full Text 
28. Nestlé Nutrition Institute: Terms and Conditions. 2018; [cited 2018 December 17]. 
Reference Source
29. Changing Markets Foundation: Milking It: How milk formula companies putting 
profits before science. Utrecht: Changing Markets Foundation; 2017.  
Reference Source
30. IBFAN-ICDC: 11th Global Monitoring Report, Breaking the rules, Stretching the 
rules. Penang: IBFAN-ICDC; 2017.  
Reference Source
31. Koletzko B, Bhutta ZA, Cai W, et al.: Compositional requirements of follow-up 
formula for use in infancy: recommendations of an international expert group 
coordinated by the Early Nutrition Academy. Ann Nutr Metab. 2013; 62(1):  
44–54.  
PubMed Abstract | Publisher Full Text 
32. Haivas I, Schroter S, Waechter F, et al.: Editors’ declaration of their own 
conflicts of interest. CMAJ. 2004; 171(5): 475–6.  
PubMed Abstract | Publisher Full Text | Free Full Text 
33. Bauchner H, Fontanarosa PB, Flanagin A: Conflicts of Interests, Authors, and 
Journals: New Challenges for a Persistent Problem. JAMA. 2018; 320(22): 
2315–8.  
PubMed Abstract | Publisher Full Text 
34. Serôdio PM, McKee M, Stuckler D: Coca-Cola - a model of transparency in 
research partnerships? A network analysis of Coca-Cola’s research funding 
(2008-2016). Public Health Nutr. 2018; 21(9): 1594–607.  
PubMed Abstract | Publisher Full Text | Free Full Text 
35. CEDAR: Diet research food industry project. Cambridge: CEDAR. 2018; [cited 
2018 December 17].  
Reference Source
Page 5 of 5
HRB Open Research 2019, 2:1 Last updated: 31 JAN 2019
